Literature DB >> 12200236

Constitutive expression of IGF-binding protein-3 by mammary epithelial cells alters signaling through Akt and p70S6 kinase.

C J Grill1, U Sivaprasad, W S Cohick.   

Abstract

IGF-binding protein-3 (IGFBP-3) potentiates IGF-I action in the non-transformed mammary epithelial cell line, MAC-T, via a mechanism that is independent of its ability to bind IGF-I. The goal of the present study was to determine if IGFBP-3 might enhance IGF action by influencing intracellular signaling events downstream of the IGF receptor. IGF-I stimulated a time-dependent activation of Akt in which phosphorylation of Ser(473) was detectable by 1 min and maximal at 15 min. In contrast, no activation of extracellular signal-regulated kinase (ERK)1/2 by IGF-I was observed although basal phosphorylation was readily detectable. In MAC-T cells constitutively expressing IGFBP-3 (+BP3), phosphorylation of Akt following stimulation with IGF-I was enhanced relative to mock-transfected cells (Mock). The enhancement was detectable within 1 min of IGF-I treatment and persisted for up to 10 h. The increased phosphorylation observed by Western blotting corresponded to a 1.7-fold increase in Akt kinase activity. The enhanced Akt response was elicited by factors that activate the IGF receptor but exhibit reduced affinity for IGFBP-3, such as Long R(3)IGF-I, B chain IGF-I and insulin. In contrast, [Leu(60)]IGF-I, which binds IGFBP-3 but has reduced affinity for the IGF receptor, failed to induce comparable activation, suggesting that an association between IGF-I and IGFBP-3 is not required for the effect. The enhanced Akt activation could not be mimicked by addition of exogenous IGFBP-3. Akt phosphorylation was also enhanced by transforming growth factor-alpha in +BP3 cells, indicating that the effect was not specific to IGF-I. Similar to Akt, phosphorylation of p70S6 kinase (p70(S6K)) by IGF-I was also enhanced in +BP3 cells relative to Mock cells at both 15 min and 10 h. However, this was largely an effect of lower basal activation of p70(S6K) in +BP3 cells. These data indicate that endogenous IGFBP-3 potentiates IGF action in MAC-T cells by enhancing signaling via the phosphatidylinositol 3-kinase pathway at a point that is downstream of IGF receptor activation. Further studies will delineate specific mechanisms by which IGFBP-3 may influence intracellular events that regulate growth in mammary epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12200236     DOI: 10.1677/jme.0.0290153

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  9 in total

1.  Insulin-like growth factor binding protein-3 mediates cytokine-induced mesangial cell apoptosis.

Authors:  Tetyana L Vasylyeva; Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-03-23       Impact factor: 2.372

2.  Ricin A-chain requires c-Jun N-terminal kinase to induce apoptosis in nontransformed epithelial cells.

Authors:  Amanda E Jetzt; Ju-Shun Cheng; Nilgun E Tumer; Wendie S Cohick
Journal:  Int J Biochem Cell Biol       Date:  2009-08-18       Impact factor: 5.085

3.  The TATA binding protein associated factor 4b (TAF4b) mediates FSH stimulation of the IGFBP-3 promoter in cultured porcine ovarian granulosa cells.

Authors:  Elimelda Moige Ongeri; Michael F Verderame; James M Hammond
Journal:  Mol Cell Endocrinol       Date:  2007-08-19       Impact factor: 4.102

4.  A relatively low level of ribosome depurination by mutant forms of ricin toxin A chain can trigger protein synthesis inhibition, cell signaling and apoptosis in mammalian cells.

Authors:  Amanda E Jetzt; Ju-Shun Cheng; Xiao-Ping Li; Nilgun E Tumer; Wendie S Cohick
Journal:  Int J Biochem Cell Biol       Date:  2012-09-12       Impact factor: 5.085

5.  The IGF-1R/AKT pathway determines cell fate in response to p53.

Authors:  Lei Duan; Carl G Maki
Journal:  Transl Cancer Res       Date:  2016-12       Impact factor: 1.241

6.  Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.

Authors:  Batzaya Davaadelger; Lei Duan; Ricardo E Perez; Steven Gitelis; Carl G Maki
Journal:  Oncotarget       Date:  2016-05-10

7.  Cyclovirobuxine inhibits the progression of clear cell renal cell carcinoma by suppressing the IGFBP3-AKT/STAT3/MAPK-Snail signalling pathway.

Authors:  Yadong Liu; Huiyan Lv; Xingyi Li; Jiannan Liu; Song Chen; Yaodong Chen; Yinshan Jin; Ruihua An; Shiliang Yu; Zhigang Wang
Journal:  Int J Biol Sci       Date:  2021-08-13       Impact factor: 6.580

8.  Oscillations of the p53-Akt network: implications on cell survival and death.

Authors:  Keng Boon Wee; Uttam Surana; Baltazar D Aguda
Journal:  PLoS One       Date:  2009-02-06       Impact factor: 3.240

9.  Leucine 232 and hydrophobic residues at the ribosomal P stalk binding site are critical for biological activity of ricin.

Authors:  Yijun Zhou; Xiao-Ping Li; Jennifer N Kahn; John E McLaughlin; Nilgun E Tumer
Journal:  Biosci Rep       Date:  2019-10-30       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.